Gomez-Navarro J - Search Results

1

An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression.

Hemminki A, Belousova N, Zinn KR, Liu B, Wang M, Chaudhuri TR, Rogers BE, Buchsbaum DJ, Siegal GP, Barnes MN, Gomez-Navarro J, Curiel DT, Alvarez RD. Hemminki A, et al. Mol Ther. 2001 Sep;4(3):223-31. doi: 10.1006/mthe.2001.0446. Mol Ther. 2001. PMID: 11545613 Free article.

2

Gene therapy: ovarian carcinoma as the paradigm.

Gómez-Navarro J, Siegal GP, Alvarez RD, Curiel DT. Gómez-Navarro J, et al. Am J Clin Pathol. 1998 Apr;109(4):444-67. doi: 10.1093/ajcp/109.4.444. Am J Clin Pathol. 1998. PMID: 9535399 Review.

3

Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy.

Rancourt C, Piché A, Gomez-Navarro J, Wang M, Alvarez RD, Siegal GP, Fuller GM, Jones SA, Curiel DT. Rancourt C, et al. Clin Cancer Res. 1999 Jan;5(1):43-50. Clin Cancer Res. 1999. PMID: 9918201

4

Targeted adenoviral vectors for cancer gene therapy.

Bilbao G, Gómez-Navarro J, Curiel DT. Bilbao G, et al. Adv Exp Med Biol. 1998;451:365-74. doi: 10.1007/978-1-4615-5357-1_57. Adv Exp Med Biol. 1998. PMID: 10026898 Review.

5

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches.

Vanderkwaak TJ, Wang M, Gómez-Navarro J, Rancourt C, Dmitriev I, Krasnykh V, Barnes M, Siegal GP, Alvarez R, Curiel DT. Vanderkwaak TJ, et al. Gynecol Oncol. 1999 Aug;74(2):227-34. doi: 10.1006/gyno.1999.5432. Gynecol Oncol. 1999. PMID: 10419736

6

Gene therapy for cancer.

Gómez-Navarro J, Curiel DT, Douglas JT. Gómez-Navarro J, et al. Eur J Cancer. 1999 Dec;35(14):2039-57. doi: 10.1016/s0959-8049(99)00300-7. Eur J Cancer. 1999. PMID: 10711245 Review. No abstract available.

7

Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer.

Xiang J, Gómez-Navarro J, Arafat W, Liu B, Barker SD, Alvarez RD, Siegal GP, Curiel DT. Xiang J, et al. J Gene Med. 2000 Mar-Apr;2(2):97-106. doi: 10.1002/(SICI)1521-2254(200003/04)2:2<97::AID-JGM99>3.0.CO;2-S. J Gene Med. 2000. PMID: 10809143

8

An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.

Arafat WO, Gómez-Navarro J, Xiang J, Barnes MN, Mahasreshti P, Alvarez RD, Siegal GP, Badib AO, Buchsbaum D, Curiel DT, Stackhouse MA. Arafat WO, et al. Mol Ther. 2000 Jun;1(6):545-54. doi: 10.1006/mthe.2000.0071. Mol Ther. 2000. PMID: 10933979 Free article.

9

Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid.

Blackwell JL, Li H, Gomez-Navarro J, Dmitriev I, Krasnykh V, Richter CA, Shaw DR, Alvarez RD, Curiel DT, Strong TV. Blackwell JL, et al. Hum Gene Ther. 2000 Aug 10;11(12):1657-69. doi: 10.1089/10430340050111313. Hum Gene Ther. 2000. PMID: 10954900

10

A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.

Alvarez RD, Barnes MN, Gomez-Navarro J, Wang M, Strong TV, Arafat W, Arani RB, Johnson MR, Roberts BL, Siegal GP, Curiel DT. Alvarez RD, et al. Clin Cancer Res. 2000 Aug;6(8):3081-7. Clin Cancer Res. 2000. PMID: 10955787 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters